PPCP
MD icon

Pivot Point Capital Partners’s Pediatrix Medical MD Stock Holding History

Pivot Point Capital Partners’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-218,114
Closed -$15.1M – 6
2017
Q1 		$15.1M Hold
218,114
– – 9.98% 5
2016
Q4 		$14.5M Buy
+218,114
New +$14.2M 8.76% 5

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Pivot Point Capital Partners's MD Position: Q2 2017 in Review

Pivot Point Capital Partners sold out of Pediatrix Medical (MD) in Q2 2017, closing a stake of 218,114 shares — an estimated $15.1M sold.

Pivot Point Capital Partners first reported a position in MD in Q4 2016 and held it in 2 quarters. The position peaked at $15.1M in Q1 2017. 332 funds tracked by Wall St. Rank hold MD as of Q2 2017.

  • Pivot Point Capital Partners reported no remaining Pediatrix Medical position as of Q2 2017 after selling out during the quarter.
  • Pivot Point Capital Partners sold 218,114 Pediatrix Medical shares in Q2 2017, an estimated $15.1M.
  • Pivot Point Capital Partners first reported a position in Pediatrix Medical in Q4 2016 and held it in 2 quarters.
  • Pivot Point Capital Partners's Pediatrix Medical position peaked at $15.1M in Q1 2017.
  • 332 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2017.

Based on Pivot Point Capital Partners's 13F filing for Q2 2017, filed 11 Aug 2017.